141 related articles for article (PubMed ID: 30099761)
1. Upregulation of C/EBPβ and TSC2 by an HDAC inhibitor CG200745 protects heart from DOCA-induced hypertrophy.
Lee E; Lee HA; Kim M; Do GY; Cho HM; Kim GJ; Jung H; Song JH; Cho JM; Kim I
Clin Exp Pharmacol Physiol; 2019 Mar; 46(3):226-236. PubMed ID: 30099761
[TBL] [Abstract][Full Text] [Related]
2. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes.
Ooi JY; Tuano NK; Rafehi H; Gao XM; Ziemann M; Du XJ; El-Osta A
Epigenetics; 2015; 10(5):418-30. PubMed ID: 25941940
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in DOCA-induced hypertensive rats.
Lee E; Song MJ; Lee HA; Kang SH; Kim M; Yang EK; Lee do Y; Ro S; Cho JM; Kim I
Korean J Physiol Pharmacol; 2016 Sep; 20(5):477-85. PubMed ID: 27610034
[TBL] [Abstract][Full Text] [Related]
4. Renoprotective Effect of the Histone Deacetylase Inhibitor CG200745 in DOCA-Salt Hypertensive Rats.
Bae EH; Kim IJ; Song JH; Choi HS; Kim CS; Eom GH; Kim I; Cha H; Cho JM; Ma SK; Kim SW
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30691015
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibition attenuates transcriptional activity of mineralocorticoid receptor through its acetylation and prevents development of hypertension.
Lee HA; Lee DY; Cho HM; Kim SY; Iwasaki Y; Kim IK
Circ Res; 2013 Mar; 112(7):1004-12. PubMed ID: 23421989
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibition attenuates cardiac hypertrophy and fibrosis through acetylation of mineralocorticoid receptor in spontaneously hypertensive rats.
Kang SH; Seok YM; Song MJ; Lee HA; Kurz T; Kim I
Mol Pharmacol; 2015 May; 87(5):782-91. PubMed ID: 25667225
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression.
Morales CR; Li DL; Pedrozo Z; May HI; Jiang N; Kyrychenko V; Cho GW; Kim SY; Wang ZV; Rotter D; Rothermel BA; Schneider JW; Lavandero S; Gillette TG; Hill JA
Sci Signal; 2016 Apr; 9(422):ra34. PubMed ID: 27048565
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of LPS-induced C/EBP delta by trichostatin A has a positive effect on LPS-induced cyclooxygenase 2 expression in RAW264.7 cells.
Liu YW; Wang SA; Hsu TY; Chen TA; Chang WC; Hung JJ
J Cell Biochem; 2010 Aug; 110(6):1430-8. PubMed ID: 20506344
[TBL] [Abstract][Full Text] [Related]
9. PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress.
Ranek MJ; Kokkonen-Simon KM; Chen A; Dunkerly-Eyring BL; Vera MP; Oeing CU; Patel CH; Nakamura T; Zhu G; Bedja D; Sasaki M; Holewinski RJ; Van Eyk JE; Powell JD; Lee DI; Kass DA
Nature; 2019 Feb; 566(7743):264-269. PubMed ID: 30700906
[TBL] [Abstract][Full Text] [Related]
10. Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy.
Evans LW; Bender A; Burnett L; Godoy L; Shen Y; Staten D; Zhou T; Angermann JE; Ferguson BS
J Nutr Biochem; 2020 May; 79():108339. PubMed ID: 32007664
[TBL] [Abstract][Full Text] [Related]
11. Involvement of C/EBPβ-related signaling pathway in methamphetamine-induced neuronal autophagy and apoptosis.
Huang E; Huang H; Guan T; Liu C; Qu D; Xu Y; Yang J; Yan L; Xiong Y; Liang T; Wang Q; Chen L
Toxicol Lett; 2019 Sep; 312():11-21. PubMed ID: 31059759
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitor CG200745 ameliorates high-fat diet-induced hypertension via inhibition of angiotensin II production.
Yoon GE; Jung JK; Lee YH; Jang BC; In Kim J
Naunyn Schmiedebergs Arch Pharmacol; 2020 Mar; 393(3):491-500. PubMed ID: 31655853
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors restore normal hippocampal synaptic plasticity and seizure threshold in a mouse model of Tuberous Sclerosis Complex.
Basu T; O'Riordan KJ; Schoenike BA; Khan NN; Wallace EP; Rodriguez G; Maganti RK; Roopra A
Sci Rep; 2019 Mar; 9(1):5266. PubMed ID: 30918308
[TBL] [Abstract][Full Text] [Related]
14. PKG1α Cysteine-42 Redox State Controls mTORC1 Activation in Pathological Cardiac Hypertrophy.
Oeing CU; Nakamura T; Pan S; Mishra S; Dunkerly-Eyring BL; Kokkonen-Simon KM; Lin BL; Chen A; Zhu G; Bedja D; Lee DI; Kass DA; Ranek MJ
Circ Res; 2020 Jul; 127(4):522-533. PubMed ID: 32393148
[TBL] [Abstract][Full Text] [Related]
15. Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats.
Iyer A; Fenning A; Lim J; Le GT; Reid RC; Halili MA; Fairlie DP; Brown L
Br J Pharmacol; 2010 Apr; 159(7):1408-17. PubMed ID: 20180942
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin Attenuates Myocardial Hypertrophy in Spontaneously Hypertensive Rats via the C/EBPβ/PGC-1α/UCP3 Pathway.
Chen Y; Chang Y; Zhang N; Guo X; Sun G; Sun Y
Cell Physiol Biochem; 2018; 46(3):1009-1018. PubMed ID: 29669326
[TBL] [Abstract][Full Text] [Related]
17. Metabolic impairment in response to early induction of C/EBPβ leads to compromised cardiac function during pathological hypertrophy.
Banerjee D; Datta Chaudhuri R; Niyogi S; Roy Chowdhuri S; Poddar Sarkar M; Chatterjee R; Chakrabarti P; Sarkar S
J Mol Cell Cardiol; 2020 Feb; 139():148-163. PubMed ID: 31958467
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of HDAC2 by magnesium valproate attenuates cardiac hypertrophy.
Raghunathan S; Goyal RK; Patel BM
Can J Physiol Pharmacol; 2017 Mar; 95(3):260-267. PubMed ID: 28177689
[TBL] [Abstract][Full Text] [Related]
19. HDAC inhibitor trichostatin A suppresses osteoclastogenesis by upregulating the expression of C/EBP-β and MKP-1.
Williams PJ; Nishu K; Rahman MM
Ann N Y Acad Sci; 2011 Dec; 1240(1):18-25. PubMed ID: 22172035
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitor induction of P-glycoprotein transcription requires both histone deacetylase 1 dissociation and recruitment of CAAT/enhancer binding protein beta and pCAF to the promoter region.
Kim SN; Kim NH; Lee W; Seo DW; Kim YK
Mol Cancer Res; 2009 May; 7(5):735-44. PubMed ID: 19435809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
